Biotech

Biotechnology in plain English: gene editing, cell therapies, diagnostics and drug discovery, separating early research from clinical evidence.

Biotech

Cancer Has Two Escape Routes. This Drug Blocks Both

Oct 9, 2026

•

7 min read

Cancer Has Two Escape Routes. This Drug Blocks Both

Phrontline has dosed the first patient with an antibody that recognizes two tumor markers and delivers two different poisons. The architecture is the news. The toxicity is the test.

Syncona

Where Two Drug Giants Failed, This Startup Just Won

Oct 2, 2026

•

7 min read

Where Two Drug Giants Failed, This Startup Just Won

Biogen and Johnson and Johnson both tried to treat an inherited form of blindness by delivering a working copy of the same faulty gene, and both trials missed. Beacon Therapeutics just hit its primary endpoint in an 85-patient trial. The honest question is whether its therapy is actually better, or whether it picked the finish line the first two had already found easier.

galantamine

Scientists Taught Yeast to Make an Alzheimer's Drug

Sep 14, 2026

•

6 min read

Scientists Taught Yeast to Make an Alzheimer's Drug

Researchers raised galantamine output 173 fold by rebuilding a daffodil enzyme pathway in yeast. The result solves a hard reaction, but it is not yet fermentation from sugar and it is nowhere near commercial scale.

nonsense mutations

Scientists Stopped Trying to Fix the Gene. They Fixed the Reader

Sep 1, 2026

•

5 min read

Scientists Stopped Trying to Fix the Gene. They Fixed the Reader

Some genetic diseases are caused by a single misplaced full stop in the middle of an instruction. The usual answer is to correct the error, which means editing DNA. A team at the University of Toronto did something else: they left the typo in place and rebuilt the molecule that reads it, then delivered the fix as something you breathe in. Here is how readthrough works, and what it would take for it to reach patients.

Biotech

The Immune Cells Gene Editing Couldn't Reach

Aug 25, 2026

•

5 min read

The Immune Cells Gene Editing Couldn't Reach

Macrophages decide what your body attacks, and their verdicts sit underneath arthritis, artery disease and the wall that keeps immunity out of a tumour. Gene editing largely skipped them, because the standard way in kills them. A new delivery vehicle changed that, and the first large genetic screen ever run in these cells has already turned something up.

Space

Aug 23, 2026

•

2 min read

The Frontier Week Ahead: Six Deep Dives, One a Day

Six days, six long-reads from the frontier, plus a featured story on orbital surveillance going mass-market. A quantum sensor that can touch a patient, gene editing reaching a cell it never could, and two bodies flown around the Moon.

cell therapy manufacturing

Moderna Didn't Beat the Bottleneck. It Paid It.

Aug 21, 2026

•

5 min read

Moderna Didn't Beat the Bottleneck. It Paid It.

Two weeks ago we explained why a $400,000 price tag and a six-week factory queue were the real limit on cancer therapy. On 19 August, Merck and Moderna won the first Phase 3 in the history of personalised cancer vaccines, using a six-week factory queue. Here is what we said, what happened, and why the point got sharper.

Space

Aug 16, 2026

•

2 min read

The Frontier Week Ahead: Six Deep Dives, One a Day

Next week on The Signal: a quantum internet, living-bacteria implants, drones that navigate by ear, AI-run cyberattacks, disposable satellites, and a salt battery, plus a featured read on where vertical-AI money is flowing.

hypoimmune cells

People Die Waiting for an Organ Every Day. This Lab Wants to Print One.

Aug 13, 2026

•

11 min read

People Die Waiting for an Organ Every Day. This Lab Wants to Print One.

Two frontiers this edition, biotech and living robots, in plain English.

Space

Aug 9, 2026

•

3 min read

The Frontier Week Ahead: Six Deep Dives, One a Day

Alien megastructures, a quantum computer that runs on light, a battery that rusts on purpose, and a living robot. Your first look at next week.

Frontier Signal

+10

The $400,000 Cancer Therapy Scientists Want Your Body to Make Itself

Aug 6, 2026

•

12 min read

The $400,000 Cancer Therapy Scientists Want Your Body to Make Itself

Plus this week's featured piece, Anti-Aging and the Billion-Dollar Race Behind It. One edition, two biotech frontiers.

Frontier Signal

Mirror Life: The Science We May Choose Not to Build

Jul 28, 2026

•

4 min read

Mirror Life: The Science We May Choose Not to Build

All life on Earth is one-handed. A few labs are learning to build the mirror image, and the scientists closest to the work are asking the world to stop before a mirror cell can copy itself.

oncology

+12

Right Drug, Wrong Patient: The AI Out to End Cancer's Costliest Mistake

Jul 20, 2026

•

5 min read

Right Drug, Wrong Patient: The AI Out to End Cancer's Costliest Mistake

A model published in Nature Medicine reads a tumour's gene activity to predict who will benefit from immunotherapy, and it works across many cancers and drugs, not just one.

Space

The Week Ahead: Six More Deep Dives, One a Day

Jul 19, 2026

•

2 min read

The Week Ahead: Six More Deep Dives, One a Day

Six deep dives, one a day, Monday to Saturday. Here is your first taste of each.

enzymatic DNA synthesis

A Chip That Writes DNA With Electricity and Water

Jul 14, 2026

•

5 min read

A Chip That Writes DNA With Electricity and Water

A Harvard-led team turned a silicon chip into a DNA printer: 64 sequences written in parallel using electric currents and enzymes in water, replacing the solvent-heavy chemistry biology has relied on since the 1980s. The printing press moment for synthetic biology.

Space

The Frontier Week Ahead: Six More Deep Dives, One a Day

Jul 12, 2026

•

2 min read

The Frontier Week Ahead: Six More Deep Dives, One a Day

Mind-reading AI, a chip that writes DNA, one free download that drives 20 robots, and the signal holding up civilisation. Six deep dives, one a day, Monday to Saturday.

Nucleus Genomics

+16

Choose the "Best" Embryo, Then Rewrite It: The New Baby Business Is Open

Jul 8, 2026

•

4 min read

Choose the "Best" Embryo, Then Rewrite It: The New Baby Business Is Open

One technology ranks IVF embryos by predicted IQ and disease; another wants to edit them. What embryo screening and gene editing can really do, and can't.

Space

Jul 5, 2026

•

2 min read

The Frontier Week Ahead: Six Deep Dives, One a Day

Six spoilers- for next week's deep dives, one a day, Monday to Saturday.

Space

AI Can Now Spot Cancer Years Before You'd Feel It

Jul 3, 2026

•

6 min read

AI Can Now Spot Cancer Years Before You'd Feel It

Plus: China's eerily lifelike humanoid, why bosses say data (not models) is the moat against LLMs, Russia's $60B bid to become SpaceX, home batteries turned power plants, and the Pentagon's encryption countdown.

AI for science

+18

Can AI Actually Do Science? A Brutal New Test Keeps Score

Jul 2, 2026

•

8 min read

Can AI Actually Do Science? A Brutal New Test Keeps Score

Plus: robots learning to feel, a contested claim to have built life from scratch, China's fusion-magnet milestone, a tiny engine aimed at Mars, and quantum error-fixing as a free download.

Space

+22

The Future of Video Editing? Tell Google's AI What to Change — and It Does It

Jul 1, 2026

•

8 min read

The Future of Video Editing? Tell Google's AI What to Change — and It Does It

Plus: a humanoid robot pulls a multi-day shift, a monthly shot that silences a gene, a battery made of CO2, NASA's private cargo run to the Moon, and a quantum computer that fits in a server rack.

SMR

+23

A Robot Tow-Truck Launches Today to Save a Falling NASA Telescope

Jun 30, 2026

•

8 min read

A Robot Tow-Truck Launches Today to Save a Falling NASA Telescope

Plus: NVIDIA hands AI agents a real science lab, robots learn from video games, a world-first cell therapy cracks a solid tumour, a walk-away-safe reactor finds a grid partner, and an AI designs quantum codes humans couldn't.

AI drug discovery

The First AI-Born Hair-Loss Drug Just Faced Humans — and Won Round One

Jun 29, 2026

•

4 min read

The First AI-Born Hair-Loss Drug Just Faced Humans — and Won Round One

No chemist drew Absci's ABS-201 — a generative AI invented the antibody for pattern hair loss and endometriosis. It just cleared the first safety checkpoint in real people; whether it works is the next question.

direct air capture

+21

The Machines Sucking CO2 From the Sky Just Got Real — and Cheaper

Jun 29, 2026

•

7 min read

The Machines Sucking CO2 From the Sky Just Got Real — and Cheaper

Plus: Washington gates the most powerful AI, a humanoid takes a real shift at BMW, an AI-designed antibody clears its first human safety test, the next Starship lights up, and quantum hits a real milestone.

Space

+18

The Signal — America's quantum moonshot, and the quiet race to lock your data first

Jun 26, 2026

•

10 min read

The Signal — America's quantum moonshot, and the quiet race to lock your data first

A US executive order pours the government into quantum computing — and braces for the day it breaks today's encryption. Plus five more signals from the frontier.